0HKD.LSE Axogen Inc.

Healthcare Oil, Gas & Consumable Fuels London Exchange
- USD
Market cap
-
P/E
-
P/B
-
ROE
-5.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0HKD.LSE undervalued?

Graham number

The Graham number of Axogen Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Axogen Inc. fundamental analysis

No fundamental analysis for Axogen Inc. yet.

Axogen Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Axogen Inc.

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product us…

Full company profile